Article Details
Retrieved on: 2024-05-03 18:06:12
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the biopharma industry's advances in biosimilar drugs, highlighting the US launch of the first Actemra® biosimilar by Fresenius Kabi and other biosimilar approvals, amid patent settlements and disputes involving companies like Roche, Genentech, and others in the context of drugs like tocilizumab and ranibizumab.
Article found on: www.jdsupra.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here